Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

The Phase 3 findings position semaglutide to become the first drug of its kind for the liver disease. But they also confirm ...

The global DNA synthesis market is set to grow by $6.5 billion over the next five years, according to a new report from Technavio. Driven by the rise of DNA synthesis-based therapeutics and automation ...

Semaglutide was associated with significantly lower AD-related medication prescriptions. Image: Shuutterstock Ozempic, the diabetes drug from Novo Nordisk that has become a rage also for its ability ...

A groundbreaking meta-analysis has revealed semaglutide’s profound impact on cardiovascular health, demonstrating reductions across multiple risk factors. The medication has shown the ability to ...

Weight management medications are transforming the landscape of obesity treatment, with semaglutide emerging as a groundbreaking solution for individuals struggling with weight loss. As demand ...

Semaglutide, the diabetes drug also known as Ozempic, has shown positive effects in treating patients with chronic kidney disease (CKD) and obesity, as revealed in an international study led by ...

Researchers from Case Western Reserve University have now found that anti-diabetes medication semaglutide, sold under brand names like Ozempic, may help lower Alzheimer’s disease risk in people ...

A 48-week oral semaglutide treatment regimen for type 2 diabetes (T2D) reduces weight and improves liver steatosis, liver stiffness, and liver enzyme levels in patients with metabolic dysfunction ...

On Tuesday, the company nominated (PDF) semaglutide to be included on the FDA’s Demonstrable Difficulties for Compounding (DDC) lists. “Semaglutide products belong on these lists due to the ...

Some people who take Ozempic or Wegovy (semaglutide) are using a method called “counting clicks” or microdosing to get a little more or less medication in each shot than the standard amount ...

So do doctors and insurers. Rybelsus is an oral form of semaglutide, the active ingredient in the widely used drug Novo sells as Ozempic for diabetes and Wegovy for obesity. The FDA has already ...